摘要
纳米中药(nano TCM)是指具有生物活性的成分、药用材料或复方,并由纳米技术处理成约100纳米的大小。纳米中药是中药现代化的产物,并应用于中医领域中。本文回顾了近15年来国内外有关纳米中药研究的文献。不同的纳米技术被用于研究不同目标的纳米中药制备技术。机械粉碎技术是中医复方纳米化材料的主要方法,以及纳米药物输送系统是在中药活性成分或活性部位的纳米化的主要途径。以纳米中药为例,提高中药的生物利用度,减少中药的副作用,实现缓释,达到靶向给药,提高药理作用,改善中药给药途径。然而,对于纳米中药研究仍有许多问题需要解决。纳米技术的主要挑战包括:中药现代化理论体系、制备工艺、安全性和稳定性等。
关键词: 乳液,脂质体,纳米颗粒,纳米中药,中药。
图形摘要
Current Drug Targets
Title:Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
Volume: 16 Issue: 13
Author(s): Yi Huang, Yinglan Zhao, Fang Liu and Songqing Liu
Affiliation:
关键词: 乳液,脂质体,纳米颗粒,纳米中药,中药。
摘要: Nano traditional Chinese medicine (nano TCM) refers to bioactive ingredients, bioactive parts, medicinal materials or complex prescription, being approximately 100 nm in size, which are processed by nanotechnology. Nano TCM is a product of the TCM modernization, and is an application of nanotechnology in the field of TCM. This article reviews literatures on researches of nano TCM, which were published in the past 15 years. Different nanotechnologies have been used in preparation of Nano TCM in view of the varying aims of the study. The mechanical crushing technology is the main approach for nanolization of TCM material and complex prescription, and nanoparticulate drug delivery systems is the main approach for nanolization of bioactive ingredients or bioactive parts in TCM. Nano TCM has a number of advantages, for example, enhancing the bioavailability of TCM, reducing the adverse effects of TCM, achieving sustained release, attaining targeted delivery, enhancing pharmacological effects and improving the administration route of TCM. However, there are still many problems that must be resolved in nano TCM research. The main challenges to nano TCM include the theory system of TCM modernization, preparation technology, safety and stability, etc.
Export Options
About this article
Cite this article as:
Yi Huang, Yinglan Zhao, Fang Liu and Songqing Liu , Nano Traditional Chinese Medicine: Current Progresses and Future Challenges, Current Drug Targets 2015; 16 (13) . https://dx.doi.org/10.2174/1389450116666150309122334
DOI https://dx.doi.org/10.2174/1389450116666150309122334 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effectiveness of Condoms for the Prevention of Sexually Transmitted Diseases
Current Women`s Health Reviews Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Activity of 2,4-Disubstituted Thiophene Derivatives: Dual Inhibitors of Lipoxygenase and Cyclooxygenase
Medicinal Chemistry Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Production of Copper Radionuclides in Compact Medical Cyclotrons using Solid Targets
Current Radiopharmaceuticals A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design Potential of Selected Antioxidants for Influenza Chemotherapy
Anti-Infective Agents in Medicinal Chemistry Complications of Paget Bone Disease: A Study of 69 Patients
Current Rheumatology Reviews Aptamers as Targeting Delivery Devices or Anti-cancer Drugs for Fighting Tumors
Current Drug Metabolism Nanotoxicity: The Toxicity Research Progress of Metal and Metal- Containing Nanoparticles
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Management of Gynaecological Cancers - An Update)
Reviews on Recent Clinical Trials Part I: Targeted Particles for Cancer Immunotherapy
Current Drug Delivery Protein-Based Voltammetric Biosensors Fabricated with Nanomaterials
Protein & Peptide Letters Anticancer Activity of the Ascidian Polyclinum Indicum against Cervical Cancer Cells (HeLa) Mediated through Apoptosis Induction
Medicinal Chemistry Evaluation of the Radioprotective Effects of Melatonin Against Ionizing Radiation-Induced Muscle Tissue Injury
Current Radiopharmaceuticals Coexistence of Type-1 Diabetes Mellitus and Papillary Thyroid Carcinoma
Current Diabetes Reviews Detection of Residual/Recurrent Cervical Disease after Successful LEEP Conization: the Possible Role of mRNA-HPV Test
Current Pharmaceutical Design Modulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer
Current Cancer Drug Targets